138 related articles for article (PubMed ID: 31184794)
1. Prophylactic management for taxane-induced nail toxicity: A systematic review and meta-analysis.
Huang KL; Lin KY; Huang TW; Loh EW; Hua YM; Su HC; Tam KW
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13118. PubMed ID: 31184794
[TBL] [Abstract][Full Text] [Related]
2. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
Can G; Aydiner A; Cavdar I
Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
[TBL] [Abstract][Full Text] [Related]
3. Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial.
Mazzega-Fabbro C; Polesel J; Spazzapan S; Meneghetti L; Montagner D; Tabaro G; Bartoletti M; Puglisi F
Clin Breast Cancer; 2023 Jun; 23(4):447-453. PubMed ID: 36997403
[TBL] [Abstract][Full Text] [Related]
4. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
Scotté F; Banu E; Medioni J; Levy E; Ebenezer C; Marsan S; Banu A; Tourani JM; Andrieu JM; Oudard S
Cancer; 2008 Apr; 112(7):1625-31. PubMed ID: 18286527
[TBL] [Abstract][Full Text] [Related]
5. Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial.
McCarthy AL; Shaban RZ; Gillespie K; Vick J
Support Care Cancer; 2014 May; 22(5):1375-83. PubMed ID: 24362908
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic Review.
Marks DH; Qureshi A; Friedman A
JAMA Dermatol; 2018 Dec; 154(12):1465-1472. PubMed ID: 30383138
[TBL] [Abstract][Full Text] [Related]
7. ONYCHOLYSIS AS A COMPLICATION OF TAXANE-BASED CHEMOTHERAPY WITH CONCOMITANT CRYOTHERAPY IN BREAST CANCER PATIENTS: TWO CASE REPORTS.
Chikhladze N; Chelidze N; Kordzaia S; Zhvania M; Khmaladze L
Georgian Med News; 2024 Jan; (346):109-112. PubMed ID: 38501631
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy.
Kim JY; Ok ON; Seo JJ; Lee SH; Ahn JS; Im YH; Park YH
Breast Cancer Res Treat; 2017 Aug; 164(3):617-625. PubMed ID: 28488142
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of interventions for taxane-induced nail toxicity in women with early breast cancer.
Morrison A; Marshall-McKenna R; McFadyen AK; Hutchison C; Rice AM; Stirling L; McIlroy P; Macpherson IR
Sci Rep; 2022 Jul; 12(1):11575. PubMed ID: 35798751
[TBL] [Abstract][Full Text] [Related]
10. Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer.
Coolbrandt A; Vancoille K; Dejaeger E; Peeters H; Laenen A; Neven P; Punie K; Wildiers H
Breast Cancer Res Treat; 2022 Apr; 192(2):293-301. PubMed ID: 34982322
[TBL] [Abstract][Full Text] [Related]
11. Nail toxicity induced by cancer chemotherapy.
Gilbar P; Hain A; Peereboom VM
J Oncol Pharm Pract; 2009 Sep; 15(3):143-55. PubMed ID: 19171552
[TBL] [Abstract][Full Text] [Related]
12. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.
Scotté F; Tourani JM; Banu E; Peyromaure M; Levy E; Marsan S; Magherini E; Fabre-Guillevin E; Andrieu JM; Oudard S
J Clin Oncol; 2005 Jul; 23(19):4424-9. PubMed ID: 15994152
[TBL] [Abstract][Full Text] [Related]
13. Extremity Cooling: A Synthesis of Cryotherapy Interventions to Reduce Peripheral Neuropathy and Nail Changes From Taxane-Based Chemotherapy.
Peyton L; Fischer-Cartlidge E
Clin J Oncol Nurs; 2019 Oct; 23(5):522-528. PubMed ID: 31538978
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy.
Bandla A; Tan S; Kumarakulasinghe NB; Huang Y; Ang S; Magarajah G; Hairom Z; Lim JSJ; Wong A; Chan G; Ngoi N; Ang E; Lee YM; Chan A; Lee SC; Thakor N; Wilder-Smith E; Sundar R
Support Care Cancer; 2020 Aug; 28(8):3691-3699. PubMed ID: 31811482
[TBL] [Abstract][Full Text] [Related]
15. Taxane-induced nail changes: incidence, clinical presentation and outcome.
Minisini AM; Tosti A; Sobrero AF; Mansutti M; Piraccini BM; Sacco C; Puglisi F
Ann Oncol; 2003 Feb; 14(2):333-7. PubMed ID: 12562663
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-induced nail toxicity: a case of severe onycholysis and topic review.
Lau CP; Hui P; Chan TC
Chin Med J (Engl); 2011 Aug; 124(16):2559-60. PubMed ID: 21933605
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
Yorulmaz A; Dogan M; Artuz F; Zengin N
Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
[TBL] [Abstract][Full Text] [Related]
18. Subungueal haemorrhages following docetaxel (taxotere) treatment.
Fenniche S; Hammami H; Badri T; Mokhtar I; Benmously R
Curr Drug Saf; 2012 Jul; 7(3):247-9. PubMed ID: 22950986
[TBL] [Abstract][Full Text] [Related]
19. The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis.
Capriotti K; Capriotti JA; Lessin S; Wu S; Goldfarb S; Belum VR; Lacouture ME
Br J Dermatol; 2015 Sep; 173(3):842-5. PubMed ID: 25704465
[No Abstract] [Full Text] [Related]
20. Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Qi WX; Shen Z; Lin F; Sun YJ; Min DL; Tang LN; He AN; Yao Y
Curr Med Res Opin; 2013 Feb; 29(2):117-25. PubMed ID: 23216340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
